NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $1.56 -0.07 (-4.29%) Closing price 04:00 PM EasternExtended Trading$1.60 +0.03 (+2.24%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Envoy Medical Stock (NASDAQ:COCH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Envoy Medical alerts:Sign Up Key Stats Today's Range$1.56▼$1.6850-Day Range$1.26▼$1.7252-Week Range$1.21▼$3.99Volume68,563 shsAverage Volume81,033 shsMarket Capitalization$33.27 millionP/E RatioN/ADividend YieldN/APrice Target$9.25Consensus RatingBuy Company OverviewEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More… Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreCOCH MarketRank™: Envoy Medical scored higher than 34% of companies evaluated by MarketBeat, and ranked 727th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Envoy Medical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.83% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Envoy Medical has recently decreased by 11.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.83% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Envoy Medical has recently decreased by 11.67%, indicating that investor sentiment is improving significantly. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Envoy Medical this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 1 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by Insiders60.50% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address COCH Stock News HeadlinesEnvoy Medical (COCH) Expected to Announce Quarterly Earnings on WednesdayMay 19, 2025 | americanbankingnews.comEnvoy Medical advances in cochlear implant trialMay 14, 2025 | investing.comElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.May 27, 2025 | Brownstone Research (Ad)Envoy Medical (COCH) Receives a Buy from Northland SecuritiesApril 24, 2025 | markets.businessinsider.comEdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap CompaniesApril 22, 2025 | globenewswire.comEnvoy Medical secures new patents for cochlear implantsFebruary 15, 2025 | msn.comEnvoy Medical announces four new patentsDecember 17, 2024 | markets.businessinsider.comEnvoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing LossDecember 16, 2024 | markets.businessinsider.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $1.43 at the beginning of 2025. Since then, COCH stock has increased by 9.1% and is now trading at $1.56. View the best growth stocks for 2025 here. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) released its quarterly earnings data on Friday, March, 28th. The company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.33) by $0.12. The firm earned $0.04 million during the quarter, compared to analyst estimates of $0.07 million. Who are Envoy Medical's major shareholders? Top institutional shareholders of Envoy Medical include Focus Partners Wealth (1.00%) and Arcus Capital Partners LLC (0.88%). Insiders that own company stock include Brent T Lucas and Mona Chetan Patel. View institutional ownership trends. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO) and CrowdStrike (CRWD). Company Calendar Last Earnings3/28/2025Today5/27/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$9.13 High Stock Price Target$9.25 Low Stock Price Target$9.00 Potential Upside/Downside+440.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,910,000.00 Net Margins-7,607.55% Pretax Margin-7,607.55% Return on EquityN/A Return on Assets-262.28% Debt Debt-to-Equity RatioN/A Current Ratio0.79 Quick Ratio0.61 Sales & Book Value Annual Sales$212,000.00 Price / Sales169.91 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-18.77Miscellaneous Outstanding Shares21,327,000Free Float7,997,000Market Cap$36.02 million OptionableNot Optionable Beta2.33 Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:COCH) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.